About Patrick Griffin, Ph.D.
Form D filings for Myosin Therapeutics in 2023 list Patrick Griffin, Ph.D. as director.
Patrick Griffin, Ph.D. first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Patrick Griffin, Ph.D. in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Patrick Griffin, Ph.D. works with at each company, as listed on that company's latest Form D.
Myosin Therapeutics Inc. · Form D/A, Mar 24, 2023
DA
Dave Adams
Director
AR
Andrew Ritter
Director
CM
Courtney Miller
President and director
RF
Robert Finizio
Director
TK
Theodore Kamenecka
Director
JS
Jackson Streeter
Director